The molecular biology of FMRP: new insights into fragile X syndrome
Joel D Richter1, Xinyu Zhao2,3
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA. joel.richter@umassmed.edu.
Abstract:
Fragile X mental retardation protein (FMRP) is the product of the fragile X mental retardation 1 gene (FMR1), a gene that - when epigenetically inactivated by a triplet nucleotide repeat expansion - causes the neurodevelopmental disorder fragile X syndrome (FXS). FMRP is a widely expressed RNA-binding protein with activity that is essential for proper synaptic plasticity and architecture, aspects of neural function that are known to go awry in FXS. Although the neurophysiology of FXS has been described in remarkable detail, research focusing on the molecular biology of FMRP has only scratched the surface. For more than two decades, FMRP has been well established as a translational repressor; however, recent whole transcriptome and translatome analyses in mouse and human models of FXS have shown that FMRP is involved in the regulation of nearly all aspects of gene expression. The emerging mechanistic details of the mechanisms by which FMRP regulates gene expression may offer ways to design new therapies for FXS.
Insights
Fragile X mental retardation protein (FMRP) regulates gene expression. Understanding its full role in fragile X syndrome (FXS) may lead to new therapeutic strategies for this neurodevelopmental disorder.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by epigenetic inactivation of the FMR1 gene.
- The fragile X mental retardation protein (FMRP) is encoded by the FMR1 gene and is crucial for synaptic plasticity and neural function.
- While FXS neurophysiology is well-studied, FMRP's molecular functions remain incompletely understood.
Purpose of the Study:
- To explore the comprehensive role of FMRP in gene expression regulation.
- To investigate emerging mechanistic details of FMRP's function beyond translational repression.
- To identify potential therapeutic targets for FXS based on FMRP's molecular mechanisms.
Main Methods:
- Whole transcriptome analyses in mouse and human FXS models.
- Translatome analyses in mouse and human FXS models.
- Investigating FMRP's regulatory activities across gene expression.
Main Results:
- FMRP's role extends beyond translational repression to encompass nearly all aspects of gene expression.
- New insights into the molecular mechanisms by which FMRP controls gene expression have been revealed.
- Data suggests FMRP is a key regulator involved in multiple facets of gene regulation.
Conclusions:
- FMRP is a multifaceted regulator of gene expression, not just a translational repressor.
- Detailed understanding of FMRP's molecular mechanisms is critical for FXS research.
- Emerging knowledge on FMRP function offers promising avenues for developing novel FXS therapies.
More Related Videos
11:10Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
10:59Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025
